These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 29130796)

  • 1. Allergen immunotherapy.
    Mannan S
    Immunotherapy; 2017 Nov; 9(15):1199-1200. PubMed ID: 29130796
    [No Abstract]   [Full Text] [Related]  

  • 2. The best allergen immunotherapy choice for mite allergic patients.
    Ciprandi G; Incorvaia C; Masieri S; Buttafava S; Frati F
    Expert Rev Clin Immunol; 2016 Jun; 12(6):603-4. PubMed ID: 26950287
    [No Abstract]   [Full Text] [Related]  

  • 3. The future of immunotherapy with individual allergens: Immunotherapy with fungi.
    Pineda F
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():36-38. PubMed ID: 29129403
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral tolerance induction in allergy: Kissing awake a sleeping beauty.
    Valenta R
    Semin Immunol; 2017 Apr; 30():1-2. PubMed ID: 29037366
    [No Abstract]   [Full Text] [Related]  

  • 5. Epicutaneous immunotherapy.
    Scheurer S; Toda M
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():25-29. PubMed ID: 29108765
    [No Abstract]   [Full Text] [Related]  

  • 6. What should drive the choice of allergen for immunotherapy in polysensitized patients?
    Ciprandi G; Incorvaia C; Puccinelli P; Dell'Albani I; Frati F
    Ann Allergy Asthma Immunol; 2012 Aug; 109(2):148-9. PubMed ID: 22840259
    [No Abstract]   [Full Text] [Related]  

  • 7. [Molecular-allergological aspects of allergen-specific immunotherapy].
    Jappe U
    Hautarzt; 2017 Apr; 68(4):271-281. PubMed ID: 28293695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and safety of subcutaneous versus sublingual immunotherapy.
    Bauer CS; Rank MA
    J Allergy Clin Immunol; 2014 Sep; 134(3):765-765.e2. PubMed ID: 25171871
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular diagnosis and immunotherapy.
    Sastre J; Sastre-Ibañez M
    Curr Opin Allergy Clin Immunol; 2016 Dec; 16(6):565-570. PubMed ID: 27685663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergy Work-Up Including Component-Resolved Diagnosis: How to Make Allergen-Specific Immunotherapy More Specific.
    Kleine-Tebbe J; Matricardi PM; Hamilton RG
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):191-203. PubMed ID: 26617235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worldwide allergen immunotherapy guidelines: Evidence and experience-based.
    Larenas-Linnemann DES
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():17-22. PubMed ID: 29108768
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy with allergens.
    Creticos PS; Norman PS
    JAMA; 1987 Nov; 258(20):2874-80. PubMed ID: 3312669
    [No Abstract]   [Full Text] [Related]  

  • 14. Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient.
    Nelson HS
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1443-1451. PubMed ID: 27687128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination for birch pollen allergy: comparison of the affinities of specific immunoglobulins E, G1 and G4 measured by surface plasmon resonance.
    Jakobsen CG; Bodtger U; Poulsen LK; Roggen EL
    Clin Exp Allergy; 2005 Feb; 35(2):193-8. PubMed ID: 15725191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the innate immune function of dendritic cells by allergen-specific immunotherapy.
    Bellinghausen I
    Clin Exp Allergy; 2010 Jan; 40(1):12-4. PubMed ID: 20205693
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in immunotherapy for allergic diseases.
    El-Qutob D; Mencia G; Fernandez-Caldas E
    Recent Pat Inflamm Allergy Drug Discov; 2014 Jan; 8(1):24-35. PubMed ID: 24237114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
    Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
    Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality requirements for allergen extracts and allergoids for allergen immunotherapy.
    Zimmer J; Bonertz A; Vieths S
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():4-11. PubMed ID: 29128092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergen extracts for immunotherapy: to mix or not to mix?
    Nony E; Martelet A; Jain K; Moingeon P
    Expert Rev Clin Pharmacol; 2016; 9(3):401-8. PubMed ID: 26652799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.